- Home
- ARCT vs LDP Comparison
ARCT vs LDP Comparison
Compare ARCT & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | LDP |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 628.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | LDP |
|---|---|---|
| Price | $6.84 | $21.32 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $38.44 | N/A |
| AVG Volume (30 Days) | ★ 627.7K | 102.5K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $97,601,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $16.16 |
| 52 Week High | $24.17 | $20.30 |
Technical Indicators
Market Signals| Indicator | ARCT | LDP |
|---|---|---|
| Relative Strength Index (RSI) | 47.68 | 53.99 |
| Support Level | $6.02 | $21.05 |
| Resistance Level | $6.75 | $21.27 |
| Average True Range (ATR) | 0.30 | 0.14 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 69.87 | 68.75 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.